2023年新药研发发展现状与未来趋势
R&D status and future trends of new drugs in 2023
韩佳 1曾文晔 1史彤 2陈琪 3谢运飞 2张华 2陈大明4
作者信息
- 1. 中国科学院上海生命科学信息中心,中国科学院上海营养与健康研究所,上海 200031
- 2. 上海市生物医药科技发展中心,上海 201203
- 3. 中国生物技术发展中心,北京 100039
- 4. 中国科学院上海生命科学信息中心,中国科学院上海营养与健康研究所,上海 200031;中国科学院大学,北京 100049
- 折叠
摘要
新药研发是制药行业的核心活动之一,成功发现和开发对疾病具有疗效的新药物需要跨学科的合作、大量的投资和对创新的不断追求.近年来全球新药研发竞争格局不断加速演变,我国众多创新药企寻求深层次变革与转型发展,并加快拓展海外市场.2023年,全球获批上市的创新药数量持续增长,同比增长17％,临床研究管线数量亦不断扩大;生物技术和基因疗法的发展日新月异,罕见病药物研发逐渐增多,免疫疗法领域研发取得显著成果.本研究从创新药物的类别和研发新格局等角度出发,对2023年新药研发发展态势进行梳理与总结,并展望未来发展趋势.
Abstract
New drug research and development are the core activities of the pharmaceutical industry.The successful discovery and development of new drugs that are effective for diseases requires interdisciplinary cooperation,massive investments,and continuous pursuit of innovation.In recent years,the global evolution of new drug research and experimental development(R&D)and competition landscape has accelerated.In China,many innovative pharmaceutical companies were also seeking in-depth changes,and transformational developments,and accelerated their overseas expansion.In 2023,the number of innovative drugs approved for marketing in the world continued to grow,with a year-on-year increase of 17％.The number of clinical research pipelines also continued to expand.In this review,we summarized and provided insights into future development trends in light of the rise of biotechnology and gene therapy,the gradual increase in drug research and development for rare diseases,and the significant progress of research and development in the field of immunotherapy.From the perspective of the categories of innovative drugs and the new pattern of R&D status,we sorted out the development trends of new drugs in 2023 and prospect the future trends in this field.
关键词
创新药/细胞与基因治疗/合同研究组织/数字技术/药物递送Key words
innovative drugs/cell and gene therapy/CRO/digital technology/drug delivery引用本文复制引用
基金项目
上海市2023年度"科技创新行动计划"软科学研究项目(23692102702)
上海市2022年度"科技创新行动计划"软科学研究项目(22692117000)
出版年
2024
NETL
NSTL
万方数据